Back
Rocket Pharmaceuticals, Inc. (RCKT)
BiotechnologyRCKT · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$3.84
+9.09%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$-2.01
ROE
-64.4%
Gross margin
0.0%
Debt/Equity
0.10x
Revenue growth
P/B ratio
Beta
Forward P/E
Rocket Pharmaceuticals, Inc. — company intelligence
Earnings surprises
Q1 2026$-0.42 vs $-0.42 est-1.2%
Q4 2025$-0.38 vs $-0.46 est+17.8%
Q3 2025$-0.45 vs $-0.52 est+12.6%
Q2 2025$-0.59 vs $-0.57 est-3.9%
Insider activity · 90 days
5 buys16 sellsnet -147,427 shares
Militello JohnSell 49,798 · May 26, 2026
Militello JohnSell 28,910 · May 26, 2026
Militello JohnBuy 51,509 · May 26, 2026
Recent SEC filings
8-K — Material event reportJun 30, 2026
8-K — Material event reportJun 12, 2026
4 — Insider transaction reportMay 28, 2026
Latest news
Regenxbio: 'Strong Buy' On FDA Course Reversal For NAVSUNLI And Potential AA DMD Filing — SeekingAlpha · 1w ago
9 Health Care Stocks Moving In Wednesday's After-Market Session — Benzinga · 2w ago
Rocket Pharmaceuticals Closes Sale Of Its Rare Pediatric Disease Priority Review Voucher For Gross Proceeds Of $180M — Benzinga · 4w ago
Rocket Pharmaceuticals, Inc. (RCKT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript — SeekingAlpha · Jun 9, 2026
Rocket Pharmaceuticals, Inc. (RCKT) Presents at Jefferies Global Healthcare Conference 2026 Transcript — SeekingAlpha · Jun 5, 2026
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About Rocket Pharmaceuticals, Inc.
Weekly undervalued picks (like RCKT)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.